Aqua Bio Technology ASA (OSL:ABTEC)
Norway
· Delayed Price · Currency is NOK 0.6000
+0.0260 (4.53%)
At close: Apr 2, 2025
Aqua Bio Technology ASA Revenue
Aqua Bio Technology ASA had revenue of 61.05M NOK in the half year ending June 30, 2024, with 4,672.31% growth. This brings the company's revenue in the last twelve months to 13.82M, up 664.08% year-over-year. In the year 2022, Aqua Bio Technology ASA had annual revenue of 7.16M with 262.49% growth.
Revenue (ttm)
13.82M
Revenue Growth
+664.08%
P/S Ratio
0.90
Revenue / Employee
3.45M
Employees
4
Market Cap
94.36M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 7.16M | 5.19M | 262.49% |
| Dec 31, 2021 | 1.98M | 1.16M | 143.11% |
| Dec 31, 2020 | 812.63K | -482.56K | -37.26% |
| Dec 31, 2019 | 1.30M | 78.16K | 6.42% |
| Dec 31, 2018 | 1.22M | -8.66M | -87.68% |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
| Dec 31, 2013 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 562.60M |
| Nordhealth AS | 537.23M |
| Photocure ASA | 525.39M |
| Vistin Pharma ASA | 429.50M |
| Hofseth BioCare ASA | 265.54M |
| ArcticZymes Technologies ASA | 108.11M |
| Omda AS | 426.27M |
| Gentian Diagnostics ASA | 152.07M |